This report was commissioned by the Sleep Health Foundation to re-estimate the cost of sleep disorders based on updated cost information and developments in the literature, which result in different methodology from the previous analysis. This report also includes a cost-utility analysis of continuous positive airway pressure (CPAP) — the most common treatment for obstructive sleep apnoea (OSA).

This report focuses on three of the most well recognised and researched sleep disorders, since these account for the majority of sleep impacts studied.

1. OSA;
2. restless legs syndrome (RLS); and
3. primary insomnia.